pyridostigmine bromide has been researched along with apnea in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Byring, RF; Engel, A; Gustafsson, B; Hackman, P; Ohno, K; Pihko, H; Udd, B | 1 |
Agus, MS; Burgess, SL; Burpee, TM; Darras, BT; Estrella, E; Kang, PB; Kunkel, LM; Mallory, LA; Nurko, S; Shaw, JG | 1 |
Brooks, S; Crenshaw, M; DiBartolomeo, M; Geller, T; Iyadurai, S; Wyrebek, R | 1 |
3 other study(ies) available for pyridostigmine bromide and apnea
Article | Year |
---|---|
[Respiratory arrests caused by congenital myasthenia gravis syndrome].
Topics: Apnea; Child; Choline O-Acetyltransferase; Cholinesterase Inhibitors; Female; Humans; Mutation; Myasthenic Syndromes, Congenital; Pyridostigmine Bromide; Treatment Outcome | 2002 |
Congenital myasthenic syndrome with episodic apnea.
Topics: Amino Acid Sequence; Apnea; Blepharoptosis; Choline O-Acetyltransferase; Cholinesterase Inhibitors; Conserved Sequence; Diagnosis, Differential; Female; Humans; Hypnotics and Sedatives; Infant; Midazolam; Molecular Sequence Data; Mutation; Myasthenic Syndromes, Congenital; Pedigree; Pyridostigmine Bromide; Respiration; Treatment Outcome | 2009 |
Hypotonic infant with PURA syndrome-related channelopathy successfully treated with pyridostigmine.
Topics: Acetylcholinesterase; Apnea; Channelopathies; DNA-Binding Proteins; Epilepsy; Humans; Infant; Intellectual Disability; Pyridostigmine Bromide; Transcription Factors | 2022 |